Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

  • Test Name: RET Mutation Analysis Test by NGS (Hotspot Regions)
  • Maximum Days for Report: 14 days

What are the prerequisites for the test RET Mutation Analysis Test by NGS (Hotspot Regions)

  • Specimen: Formalin-fixed, paraffin-embedded (FFPE) tumor tissue block or slides
  • Specimen Requirements: Minimum 10% tumor content
  • Specimen Stability: FFPE blocks or slides stored at room temperature
  • Turnaround Time: 7-10 days
  • Methodology: Next-generation sequencing (NGS) of hotspot regions
  • Test Includes: Detection of RET mutations in hotspot regions

What are the measure values for the test RET Mutation Analysis Test by NGS (Hotspot Regions)

  • Test Name: RET Mutation Analysis Test by NGS (Hotspot Regions)
  • Measure Values:
    • - Negative: No mutations detected in hotspot regions of RET gene
    • - Positive: Mutations detected in hotspot regions of RET gene

What does this test RET Mutation Analysis Test by NGS (Hotspot Regions) identify?

RET Mutation Analysis Test by NGS (Hotspot Regions)

The RET Mutation Analysis Test by NGS (Next Generation Sequencing) is a diagnostic test that identifies specific mutations in the RET gene within hotspot regions. The RET gene is known to be associated with various cancers, including thyroid cancer and multiple endocrine neoplasia.

By analyzing the hotspot regions of the RET gene using NGS technology, this test can detect mutations that may be driving the development of cancer. This information is crucial for determining the most appropriate treatment options for patients with RET gene mutations.

Overall, the RET Mutation Analysis Test by NGS (Hotspot Regions) helps healthcare providers to personalize cancer treatment strategies based on the specific genetic profile of each patient.

Why is this test RET Mutation Analysis Test by NGS (Hotspot Regions) taken?

The RET Mutation Analysis Test by NGS (Hotspot Regions) is taken to identify mutations in the RET gene that are associated with certain types of cancer, particularly thyroid cancer. The RET gene plays a critical role in cell growth and division, and mutations in this gene can lead to uncontrolled cell growth and the formation of tumors.

By analyzing the hotspot regions of the RET gene using Next Generation Sequencing (NGS) technology, healthcare providers can determine if a patient has any mutations that may be driving their cancer. This information can help guide treatment decisions, such as the use of targeted therapies that specifically target the mutated RET gene.

Overall, the RET Mutation Analysis Test by NGS (Hotspot Regions) is important for diagnosing and managing cancer patients, as it provides valuable information about the genetic alterations driving their disease.

No FAQs available.

Customer Google Rating